Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
J Infect Dis. 2023 Aug 31;228(5):615-626. doi: 10.1093/infdis/jiad055.
Human papillomavirus (HPV) vaccination coverage remains suboptimal in the United States, underscoring the importance of monitoring trends in vaccine hesitancy.
Cross-sectional data from the 2011-2020 National Immunization Survey-Teen were used to assess trends in HPV vaccination initiation among 13-17-year-olds, parental intent to initiate vaccination, and primary reasons for parental hesitancy.
Among all sex and race and ethnicity groups, the prevalence of HPV vaccination initiation increased over time, but parental intent to vaccinate against HPV for unvaccinated teens remained consistently low (≤45%). Among hesitant parents, "safety concerns" increased in nearly all demographic groups, with the greatest increases observed for non-Hispanic white female and male teens and no change for non-Hispanic black female teens. In 2019-2020, parents of unvaccinated non-Hispanic white teens were least likely to intend on vaccinating their teens, and the most common reason for hesitancy varied by sex and race and ethnicity (eg, "safety concerns" for white teens and "not necessary" for black female teens).
Although HPV vaccination initiation increased over time, a substantial fraction of parents remain hesitant, and trends in their reason varied by sex and race and ethnicity. Health campaigns and clinicians should address vaccine safety and necessity.
人乳头瘤病毒(HPV)疫苗接种率在美国仍然不理想,这突显了监测疫苗犹豫趋势的重要性。
使用 2011-2020 年国家免疫调查-青少年的横断面数据,评估 13-17 岁青少年 HPV 疫苗接种起始率、父母接种意愿以及父母犹豫的主要原因的趋势。
在所有性别和种族群体中,HPV 疫苗接种起始率随时间推移而增加,但未接种疫苗的青少年父母接种 HPV 疫苗的意愿持续较低(≤45%)。在犹豫不决的父母中,“安全问题”在几乎所有人口统计学群体中都有所增加,其中非西班牙裔白种男性和女性青少年的增幅最大,而非西班牙裔黑种女性青少年的增幅则没有变化。在 2019-2020 年,未接种疫苗的非西班牙裔白种青少年的父母最不可能打算为其青少年接种疫苗,而犹豫的最常见原因因性别和种族而异(例如,白人青少年的“安全问题”和黑人女性青少年的“不必要”)。
尽管 HPV 疫苗接种起始率随时间推移而增加,但仍有相当一部分父母犹豫不决,而且他们犹豫的趋势因性别和种族而异。健康运动和临床医生应解决疫苗安全性和必要性问题。